Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation TCT 2016

TCT 810: Percutaneous Mitral Valve Repair for Management of Systolic Anterior Motion and Mitral Regurgitation Associated with Hypertrophic Cardiomyopathy

Presenter: Brij Maini, James E. Muller

October 31, 2016

Presentation TCT 2016

TCT 500: Global Right Ventricular Longitudinal Peak Systolic Strain Predicts clinical Outcome After Pulmonary Artery Denervation for Patients with Pulmonary Arterial Hypertension

Presenter: Irene M. Lang, Ehtisham Mahmud

October 30, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Conference News TCT 2015

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

October 11, 2015

News Conference News TCT 2015

SYMPLICITY HTN-3 Results Continue to Spur Discussion

October 11, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease

Todd Neale

October 31, 2014

News Conference News TCT 2014

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

September 16, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation

September 16, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

Yael L. Maxwell

September 15, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Conference News TCT 2013

Renal Denervation Systems Show Persistent Reductions in BP

October 30, 2013

News Conference News TCT 2013

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

October 30, 2013

Presentation TCT 2013

Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability)

Presenter: Robert Bonow

October 29, 2013

Presentation TCT 2013

TCT-87. Targeting systolic anterior motion and left ventricular outflow tract obstruction in hypertrophic obstructed cardiomyopathy with a MitraClip

Presenter: Ulrich Schaefer

October 29, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

News Conference News TCT 2013

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

October 28, 2013

$Improvement in LV systolic function with ischemia guided (fractional flow reserve) chronic total occlusion (CTO) intervention$

Presentation TCT 2013

Improvement in LV systolic function with ischemia guided (fractional flow reserve) chronic total occlusion (CTO) intervention

Presenter: Mayank Agrawal, Barry Uretsky, Rajesh Sachdeva

January 31, 2013

Advertisement

TCT 810: Percutaneous Mitral Valve Repair for Management of Systolic Anterior Motion and Mitral Regurgitation Associated with Hypertrophic Cardiomyopathy

TCT 500: Global Right Ventricular Longitudinal Peak Systolic Strain Predicts clinical Outcome After Pulmonary Artery Denervation for Patients with Pulmonary Arterial Hypertension

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Companies With Innovative Technologies Compete in TCT Shark Tank

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

SYMPLICITY HTN-3 Results Continue to Spur Discussion

Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

Experts Debate Future of Renal Denervation

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Experts Debate Future of Renal Denervation Therapy

Renal Denervation Systems Show Persistent Reductions in BP

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability)

TCT-87. Targeting systolic anterior motion and left ventricular outflow tract obstruction in hypertrophic obstructed cardiomyopathy with a MitraClip

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

Preliminary Data Show Potential of Renal Denervation in Several Settings

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

Improvement in LV systolic function with ischemia guided (fractional flow reserve) chronic total occlusion (CTO) intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content